159 related articles for article (PubMed ID: 22108913)
1. Rosiglitazone and metformin have opposite effects on intestinal absorption of oligopeptides via the proton-dependent PepT1 transporter.
Hindlet P; Barraud C; Boschat L; Farinotti R; Bado A; Buyse M
Mol Pharmacol; 2012 Mar; 81(3):319-27. PubMed ID: 22108913
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of leptin on H+-coupled peptide cotransporter 1 activity and expression in vivo: evidence in leptin-deficient mice.
Hindlet P; Bado A; Farinotti R; Buyse M
J Pharmacol Exp Ther; 2007 Oct; 323(1):192-201. PubMed ID: 17622573
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
4. Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor alpha.
Shimakura J; Terada T; Saito H; Katsura T; Inui K
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G851-6. PubMed ID: 16751172
[TBL] [Abstract][Full Text] [Related]
5. Uptake, transport and regulation of JBP485 by PEPT1 in vitro and in vivo.
Liu Z; Wang C; Liu Q; Meng Q; Cang J; Mei L; Kaku T; Liu K
Peptides; 2011 Apr; 32(4):747-54. PubMed ID: 21262302
[TBL] [Abstract][Full Text] [Related]
6. Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance.
Do TT; Hindlet P; Waligora-Dupriet AJ; Kapel N; Neveux N; Mignon V; Deloménie C; Farinotti R; Fève B; Buyse M
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E668-80. PubMed ID: 24425764
[TBL] [Abstract][Full Text] [Related]
7. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.
Rong JX; Qiu Y; Hansen MK; Zhu L; Zhang V; Xie M; Okamoto Y; Mattie MD; Higashiyama H; Asano S; Strum JC; Ryan TE
Diabetes; 2007 Jul; 56(7):1751-60. PubMed ID: 17456854
[TBL] [Abstract][Full Text] [Related]
8. Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH.
Chen M; Singh A; Xiao F; Dringenberg U; Wang J; Engelhardt R; Yeruva S; Rubio-Aliaga I; Nässl AM; Kottra G; Daniel H; Seidler U
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G265-74. PubMed ID: 20430876
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
10. Mice lacking the intestinal peptide transporter display reduced energy intake and a subtle maldigestion/malabsorption that protects them from diet-induced obesity.
Kolodziejczak D; Spanier B; Pais R; Kraiczy J; Stelzl T; Gedrich K; Scherling C; Zietek T; Daniel H
Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(10):G897-907. PubMed ID: 23494121
[TBL] [Abstract][Full Text] [Related]
11. Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulation.
Hindlet P; Bado A; Kamenicky P; Deloménie C; Bourasset F; Nazaret C; Farinotti R; Buyse M
J Biol Chem; 2009 Mar; 284(11):6801-8. PubMed ID: 19144638
[TBL] [Abstract][Full Text] [Related]
12. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
[TBL] [Abstract][Full Text] [Related]
13. Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cells.
Wang W; Liu Q; Wang C; Meng Q; Kaku T; Liu K
Peptides; 2011 May; 32(5):946-55. PubMed ID: 21310202
[TBL] [Abstract][Full Text] [Related]
14. Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.
Molinuevo MS; Schurman L; McCarthy AD; Cortizo AM; Tolosa MJ; Gangoiti MV; Arnol V; Sedlinsky C
J Bone Miner Res; 2010 Feb; 25(2):211-21. PubMed ID: 19594306
[TBL] [Abstract][Full Text] [Related]
15. Role of insulin on jejunal PepT1 expression and function regulation in diabetic male and female rats.
Der-Boghossian AH; Saad SR; Perreault C; Provost C; Jacques D; Kadi LN; Issa NG; Sibai AM; El-Majzoub NW; Bikhazi AB
Can J Physiol Pharmacol; 2010 Jul; 88(7):753-9. PubMed ID: 20651823
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
17. Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1.
Nässl AM; Rubio-Aliaga I; Fenselau H; Marth MK; Kottra G; Daniel H
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G128-37. PubMed ID: 21350187
[TBL] [Abstract][Full Text] [Related]
18. Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice.
Caton PW; Kieswich J; Yaqoob MM; Holness MJ; Sugden MC
Diabetes Obes Metab; 2011 Dec; 13(12):1097-104. PubMed ID: 21733059
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin and oleic acid on adipocyte expression of resistin.
Rea R; Donnelly R
Diabetes Obes Metab; 2006 Jan; 8(1):105-9. PubMed ID: 16367888
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
Walker GE; Marzullo P; Verti B; Guzzaloni G; Maestrini S; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2008 Sep; 16(9):1983-91. PubMed ID: 19186324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
